These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 17661172)

  • 21. Use of expression data and the CGEMS genome-wide breast cancer association study to identify genes that may modify risk in BRCA1/2 mutation carriers.
    Walker LC; Waddell N; Ten Haaf A; ; Grimmond S; Spurdle AB
    Breast Cancer Res Treat; 2008 Nov; 112(2):229-36. PubMed ID: 18095154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polymorphisms in BRCA2 resulting in aberrant codon-usage and their analysis on familial breast cancer risk.
    Yang R; Chen B; Hemminki K; Wappenschmidt B; Engel C; Sutter C; Ditsch N; Weber BH; Niederacher D; Arnold N; Meindl A; Bartram CR; Schmutzler RK; Burwinkel B
    Breast Cancer Res Treat; 2009 Nov; 118(2):407-13. PubMed ID: 19229607
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Novel BRCA1 gene mutations in breast cancer patients from St. Petersburg].
    Tikhomirova OS; Grudinina NA; Golubkov VI; Mandel'shtam MIu; Vasil'ev BV
    Genetika; 2007 Sep; 43(9):1263-8. PubMed ID: 17990525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single cell diagnosis using comparative genomic hybridization after preliminary DNA amplification still needs more tweaking: too many miscalls.
    Fragouli E; Delhanty JD; Wells D
    Fertil Steril; 2007 Jul; 88(1):247-8; author reply 248-9. PubMed ID: 17548081
    [No Abstract]   [Full Text] [Related]  

  • 25. Prediction of BRCA1-association in hereditary non-BRCA1/2 breast carcinomas with array-CGH.
    Joosse SA; van Beers EH; Tielen IH; Horlings H; Peterse JL; Hoogerbrugge N; Ligtenberg MJ; Wessels LF; Axwijk P; Verhoef S; Hogervorst FB; Nederlof PM
    Breast Cancer Res Treat; 2009 Aug; 116(3):479-89. PubMed ID: 18704682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-resolution oligonucleotide array-CGH applied to the detection and characterization of large rearrangements in the hereditary breast cancer gene BRCA1.
    Rouleau E; Lefol C; Tozlu S; Andrieu C; Guy C; Copigny F; Nogues C; Bieche I; Lidereau R
    Clin Genet; 2007 Sep; 72(3):199-207. PubMed ID: 17718857
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Whole-genome amplification of oral rinse self-collected DNA in a population-based case-control study of breast cancer.
    Liang X; Trentham-Dietz A; Titus-Ernstoff L; Newcomb PA; Welch RA; Hutchinson AA; Hampton JM; Sutcliffe CB; Haines JL; Egan KM
    Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1610-4. PubMed ID: 17684135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnosis of genetic abnormalities in developmentally delayed patients: a new strategy combining MLPA and array-CGH.
    Kriek M; Knijnenburg J; White SJ; Rosenberg C; den Dunnen JT; van Ommen GJ; Tanke HJ; Breuning MH; Szuhai K
    Am J Med Genet A; 2007 Mar; 143A(6):610-4. PubMed ID: 17318845
    [No Abstract]   [Full Text] [Related]  

  • 29. An integrative hypothesis about the origin and development of sporadic and familial breast cancer subtypes.
    Melchor L; Benítez J
    Carcinogenesis; 2008 Aug; 29(8):1475-82. PubMed ID: 18596026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Copy number variations in the NF1 gene region are infrequent and do not predispose to recurrent type-1 deletions.
    Steinmann K; Kluwe L; Cooper DN; Brems H; De Raedt T; Legius E; Mautner VF; Kehrer-Sawatzki H
    Eur J Hum Genet; 2008 May; 16(5):572-80. PubMed ID: 18212816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BRCA1 breast cancer risk is modified by CYP19 polymorphisms in Ashkenazi Jews.
    Raskin L; Lejbkowicz F; Barnett-Griness O; Dishon S; Almog R; Rennert G
    Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1617-23. PubMed ID: 19366906
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
    Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; ;
    J Natl Cancer Inst; 2008 Nov; 100(21):1519-29. PubMed ID: 18957670
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification and in silico analysis of functional SNPs of the BRCA1 gene.
    Rajasekaran R; Sudandiradoss C; Doss CG; Sethumadhavan R
    Genomics; 2007 Oct; 90(4):447-52. PubMed ID: 17719744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distinct genomic aberration patterns are found in familial breast cancer associated with different immunohistochemical subtypes.
    Melchor L; Honrado E; García MJ; Alvarez S; Palacios J; Osorio A; Nathanson KL; Benítez J
    Oncogene; 2008 May; 27(22):3165-75. PubMed ID: 18071313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of a novel BRCA1 large genomic rearrangement in a Spanish breast/ovarian cancer family.
    Palanca Suela S; Esteban Cardeñosa E; Barragán González E; Oltra Soler S; de Juan Jiménez I; Chirivella González I; Segura Huerta A; Guillén Ponce C; Martínez de Dueñas E; Bolufer Gilabert P;
    Breast Cancer Res Treat; 2008 Nov; 112(1):63-7. PubMed ID: 18060491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detecting copy number changes in genomic DNA: MAPH and MLPA.
    White SJ; Breuning MH; den Dunnen JT
    Methods Cell Biol; 2004; 75():751-68. PubMed ID: 15603451
    [No Abstract]   [Full Text] [Related]  

  • 37. Convenient detection of single nucleotide polymorphism haplotypes in the bovine growth hormone gene using amplification-created restriction sites.
    Meade KG; Hill EW; Buckley F; MacHugh DE
    Anim Genet; 2005 Apr; 36(2):175-7. PubMed ID: 15771738
    [No Abstract]   [Full Text] [Related]  

  • 38. A new trend in personalized medicine: rapid detection of SNPs in drug transporter genes by the SmartAmp method.
    Aw W; Lezhava A; Hayashizaki Y; Ishikawa T
    Clin Pharmacol Ther; 2011 Apr; 89(4):617-20. PubMed ID: 21346755
    [No Abstract]   [Full Text] [Related]  

  • 39. Targeted sequencing by proximity ligation for comprehensive variant detection and local haplotyping.
    de Vree PJ; de Wit E; Yilmaz M; van de Heijning M; Klous P; Verstegen MJ; Wan Y; Teunissen H; Krijger PH; Geeven G; Eijk PP; Sie D; Ylstra B; Hulsman LO; van Dooren MF; van Zutven LJ; van den Ouweland A; Verbeek S; van Dijk KW; Cornelissen M; Das AT; Berkhout B; Sikkema-Raddatz B; van den Berg E; van der Vlies P; Weening D; den Dunnen JT; Matusiak M; Lamkanfi M; Ligtenberg MJ; ter Brugge P; Jonkers J; Foekens JA; Martens JW; van der Luijt R; van Amstel HK; van Min M; Splinter E; de Laat W
    Nat Biotechnol; 2014 Oct; 32(10):1019-25. PubMed ID: 25129690
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A hybridization-chain-reaction-based method for amplifying immunosignals.
    Lin R; Feng Q; Li P; Zhou P; Wang R; Liu Z; Wang Z; Qi X; Tang N; Shao F; Luo M
    Nat Methods; 2018 Apr; 15(4):275-278. PubMed ID: 29481551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.